Cinryze offers
the power of
proven prevention

Routine C1-INH therapy for the prevention of HAE attacks

CINRYZE® (C1 esterase inhibitor [human]) is the first C1 esterase inhibitor C1-INH approved by the FDA to help prevent swelling attacks. CINRYZE can help reduce how often attacks occur, how severe they are, and how long they last.
Choose the power of prevention for your own journey with HAE.

Scott, a real HAE
patient,
helps
prevent his

attacks with
CINRYZE

The first C1-INH therapy indicated to help prevent HAE attacks in children (6 years of age and older), teenagers and adults

Routine C1-INH therapy for the prevention of HAE attacks

CINRYZE® (C1 esterase inhibitor [human]) is the first C1 esterase inhibitor C1-INH approved by the FDA to help prevent swelling attacks. CINRYZE can help reduce how often attacks occur, how severe they are and how long they last.
Choose the power of prevention for your own journey with HAE.

WHERE ARE YOU IN YOUR JOURNEY?

Could HAE be holding you back? We're here to connect you with helpful information, resources, and tools.

Talk with your doctor

Some people with HAE have searched for an accurate diagnosis for approximately 10 years before being diagnosed. Are you ready to discuss your symptoms with your doctor?

Create your discussion guide

On average, an untreated patient will experience 2 to 4 attacks each month. If you're interested in learning about preventive therapy, move forward by talking with your doctor.

Create your discussion guide

Did you know a healthcare professional can teach you to self-administer CINRYZE? If you're ready to move forward, learn about our free training program.

Explore self-administration training

On average, an untreated patient will experience 2 to 4 attacks each month. Are you ready to learn about how CINRYZE can help prevent HAE attacks? Take the next step.

Learn about CINRYZE

Get on the Path
to Prevention

Start learning about proven prevention with CINRYZE and explore resources and support for your journey with HAE.

Learn about pediatric use

Find out more about the expanded use of CINRYZE to include patients aged 6 to 11.

Learn More

Talk to your doctor

Take the first step by sharing your symptoms with your doctor.

Start my discussion guide


Get product support

See how OnePath® can help with product support.

Learn about OnePath

Learn about self-administration

Before you self-administer CINRYZE, you will need to be trained by a healthcare professional.

Find out more

Talk to your doctor

Take the first step by sharing your symptoms with your doctor.

Start my discussion guide

Learn about HAE

Prepare for your conversation with your doctor by getting the facts.

See symptoms and triggers


Explore HAE diagnosis

See why HAE symptoms can be misdiagnosed and how doctors reach an accurate diagnosis.

Find out more

See our resources

Explore educational materials you can download and print.

Start browsing

Talk to your doctor

Take the first step by sharing your symptoms with your doctor.

Start my discussion guide

Get product support

See how OnePath® can help with product support.

Learn about OnePath


Learn about self-administration

Before you self-administer CINRYZE, you will need to be trained by a healthcare professional.

Find out more

See our resources

Explore educational materials you can download and print.

Start browsing

Learn about self-administration

Before you self-administer CINRYZE, you will need to be trained by a healthcare professional.

Find out more

Take CINRYZE as prescribed

Staying on track with your CINRYZE doses is important to help prevent HAE attacks.

Learn about prevention


See our resources

Explore educational materials you can download and print.

Start browsing

CINRYZE for pediatric patients

Find out more about the expanded use of CINRYZE to include patients aged 6 to 11.

Learn More

Learn about HAE

Find out as much as you can about your loved one's condition.

See the symptoms

Explore CINRYZE

See how CINRYZE works to prevent HAE attacks.

See how CINRYZE works


CINRYZE for pediatric patients

Find out more about the expanded use of CINRYZE to include patients aged 6 to 11.

Learn More

See our resources

Explore educational materials you can download and print.

Start browsing

Definition: